--- case_id: "3094" title: "Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation" research_checked: "2026-10-28" research_level: "documents" screening_approved: false settlement_availability: "not verified" care_availability: "not confirmed" --- # GLP-1 medicines & digestive injuries MDL 3094 ## What this matter is about This proceeding groups personal-injury claims involving GLP-1 medicines and alleged gastrointestinal injuries. Court materials discuss issues including warnings and gastroparesis. The manufacturers deny the allegations; individual use, medical history and causation still require review. Basis: [Court source](https://www.paed.uscourts.gov/mdl/mdl-3094-re-glucagon-peptide-1-receptor-agonists-glp-1-ras-products-liability-litigation-gi). ## Verified index information - **Full title:** Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation - **District:** PAE - **Master docket:** 2:24-md-3094 - **Judge:** Marston, Karen S. - **Index report date:** 2026-10-01 - **Report relationship:** Listed in this report - [JPML report](https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_MDL_Type-October-1-2026.pdf#page=5) ## Preparation roadmap This is a preparation path, not a court schedule or a promise of a payout. 1. **Understand the matter.** Read the case overview and inspect its official sources. Keep allegations separate from findings. 2. **Explore your connection.** Use optional preparation questions. Interest in a matter is not proof of a claim. 3. **Build your record trail.** Product, medicine or device identity, if known. Add only what you already know or can verify. 4. **Make room for care.** Discuss health concerns independently of any legal claim. Clinical decisions belong with your care team. 5. **Choose professional review.** Start with your existing lawyer if represented. A lawyer reviews deadlines, jurisdiction and any filing or settlement options. ## Existing records that may help - Product, medicine or device identity, if known - An approximate timeline and existing receipts or records - Existing clinical reports and treating-team information ## Care information — separate from legal eligibility ### Digestive-health review A clinician can review digestive symptoms, medicine history and existing test reports. The NIDDK describes assessment using history, examination and tests chosen by the clinician; Settlefy does not select tests or diagnose gastroparesis. - What do my existing reports actually say? - How should my prescribing and digestive-care clinicians coordinate? General information: [NIDDK: diagnosis of gastroparesis](https://www.niddk.nih.gov/health-information/digestive-diseases/gastroparesis/diagnosis). This does not establish product-specific causation or an available appointment. Care may be accessed independently of a lawsuit. Provider fit, licensure, location, insurance, price and appointment availability have not been confirmed. Settlefy does not prescribe treatment, order tests, promise a cure or recommend stopping medication. Optional OPHealth: user-selected signed reports and measurements can be copied for private review. This is not a booked appointment, provider referral or ongoing medical monitoring. No record is sent to a lawyer through that connection. ## Research material and provenance ### IN THE UNITED STATES DISTRICT COURT - [Original source](https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/24md3094_sched-ord_6.pdf) - Access: Retrieved and text-extracted; current legal interpretation still needs professional review - Retrieved: 2026-10-28T23:20:23.105Z - SHA-256: bf9f79f995bf2908191daeec65c90950184580c9047594b26b31479a8e447528 - Text inspection: first 1 PDF pages; attachments or later pages may not be covered. ### MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation (GI Injuries) | Eastern District of Pennsylvania | United States District Court - [Original source](https://www.paed.uscourts.gov/mdl/mdl-3094-re-glucagon-peptide-1-receptor-agonists-glp-1-ras-products-liability-litigation-gi) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ### MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation | Eastern District of Pennsylvania | United States District Court - [Original source](https://www.paed.uscourts.gov/mdl/mdl3094/orders) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ### IN THE UNITED STATES DISTRICT COURT - [Original source](https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/24md3094_cm-ord_18.pdf) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ### Case MDL No. 3094 Document 272 Filed 12/12/24 Page 1 of 3 - [Original source](https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3094-Transfer_Order-12-24.pdf) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ## Research gaps and professional review - Verify the operative complaint, later amendments and current court orders. - Verify any settlement notice, administrator, release, deadline and currently open intake. - Obtain current counsel-approved screening criteria; no eligibility rules are approved here. - Have qualified clinicians review any clinical mapping; general care sources are not case criteria. ## Updates [Live case page and source-update coverage](https://settlefy.com/litigation/3094#case-updates). Source checks run every six hours; most matters have directory-only monitoring. This file is a dated research brief, not an automatically updated court docket. ## Your next step [Explore the preparation questions](https://settlefy.com/my-settlefy?case=3094). Nothing is filed or sent to a firm automatically.